BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3967503)

  • 1. Urokinase treatment of pulmonary artery thrombosis complicating the pediatric nephrotic syndrome.
    Beaufils F; Schlegel N; Loirat C; Marotte R; Pillion G; Mathieu H
    Crit Care Med; 1985 Feb; 13(2):132-4. PubMed ID: 3967503
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase and AT-III concentrate treatment in inferior vena cava thrombosis associated with nephrotic syndrome.
    Storti S; Pagano L; Marra R; Grilli A; Falappa G; De Gaetano AM; Ferrante AM; Bizzi B
    Blood Coagul Fibrinolysis; 1990 Dec; 1(6):743-5. PubMed ID: 2133253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High dose urokinase against massive pulmonary embolism in nephrotic syndrome.
    Chen G; Liu Y; Xie Y; Li J; Liu H; Sun L; Peng Y; Liu F
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):439-43. PubMed ID: 23386277
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous renal arterial and venous thrombosis associated with idiopathic nephrotic syndrome: treatment with intra-arterial urokinase.
    Kennedy JS; Gerety BM; Silverman R; Pattison ME; Siskind MS; Pond GD
    Am J Med; 1991 Jan; 90(1):124-7. PubMed ID: 1986579
    [No Abstract]   [Full Text] [Related]  

  • 5. [Nephrotic syndrome complicated with intracranial venous thrombosis treated with urokinase: report of 5 cases].
    Xia ZK; He X; Fan ZM; Liu GL; Gao YF; Fu J; Ren XG; Mao S; Huang Q
    Zhonghua Er Ke Za Zhi; 2010 May; 48(5):338-41. PubMed ID: 20654032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of urokinase on fibrinolysis and fibrinogenolysis.
    Matsuo O; Nishida Y; Akazawa K; Mihara H
    Jpn J Physiol; 1982; 32(5):879-83. PubMed ID: 6759739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of dose regimens for the administration of recombinant pro-urokinase in a canine thrombosis model.
    Burke SE; Lubbers NL; Nelson RA; Henkin J
    Thromb Haemost; 1997 May; 77(5):1025-30. PubMed ID: 9184422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged local infusion of streptokinase in pulmonary artery thrombosis with nephrotic syndrome.
    Share A; Uzun O; Blackburn ME; Gibbs JL
    Pediatr Nephrol; 1996 Dec; 10(6):734-6. PubMed ID: 8971892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Thrombolytic effect of urokinase upon various methods of administration into the body].
    Andreenko GV; Serebriakova TN; Podorol'skaia LV; Afanasenko GA; Liaginskiĭ AV; Raevskaia AK
    Vopr Med Khim; 1992; 38(1):44-6. PubMed ID: 1441294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thrombolytic therapy of renal vein thrombi and follow-up.
    Wu ZL; Zhou KR; Liao LT
    Clin Nephrol; 1994 Oct; 42(4):276-7. PubMed ID: 7834924
    [No Abstract]   [Full Text] [Related]  

  • 11. [Successful lysis therapy in acute unilateral renal vein thrombosis].
    Hambrecht R; Fiehn E; Schuler G; Bode C; Andrassy K; Kübler W
    Dtsch Med Wochenschr; 1993 Dec; 118(49):1803-6. PubMed ID: 8253043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hemostatic abnormalities in nephrotic syndrome.
    Abdullah R
    Vet Clin North Am Small Anim Pract; 1988 Jan; 18(1):105-13. PubMed ID: 3282374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute subclavian and brachial artery thrombosis as a complication of the nephrotic syndrome.
    Witz M; Lehman J; Shnaker A; Korzets Z
    Isr Med Assoc J; 2004 Jul; 6(7):441-2. PubMed ID: 15274542
    [No Abstract]   [Full Text] [Related]  

  • 14. [CT examination for renal vein thrombosis in nephrotic syndrome and the effect of thrombolytic therapy].
    Wu Z; Zhou K; Liao L
    Zhonghua Nei Ke Za Zhi; 1995 Mar; 34(3):153-6. PubMed ID: 7648933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy for femoral artery thrombosis after left cardiac catheterization in children.
    Liu Q; Yan CW; Zhao SH; Jiang SL; Xu ZY; Huang LJ; Ling J; Zheng H; Wang Y
    Chin Med J (Engl); 2009 Apr; 122(8):931-4. PubMed ID: 19493417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombin inhibitory and clot-specific fibrinolytic activities of the urokinase variant, M23 (rscu-PA-40 kDa/Hir).
    Schneider J; Wnendt S; Saunders D; Heinzel-Wieland R; Wilffert B; Steffens G
    Eur J Pharmacol; 1996 Apr; 302(1-3):69-77. PubMed ID: 8790994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urokinase prophylactic anticoagulation in children with nephrotic syndrome: a multicenter retrospective cohort study.
    Wang Z; Wang N; Chen R; Tang H; Lin Q; Li X
    BMC Nephrol; 2024 Feb; 25(1):68. PubMed ID: 38408912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nephrotic syndrome with renal vein thrombosis: pathogenetic importance of a plasmin inhibitor (alpha 2-antiplasmin).
    Du XH; Glas-Greenwalt P; Kant KS; Allen CM; Hayes S; Pollak VE
    Clin Nephrol; 1985 Oct; 24(4):186-91. PubMed ID: 3933871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Primary nephrotic syndrome treated with urokinase--a report of 20 cases].
    Wang LS; Chen EH; Zhou XJ
    Zhonghua Nei Ke Za Zhi; 1989 Jun; 28(6):356-9, 382. PubMed ID: 2582915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of streptokinase and urokinase on microarterial thrombosis and haemostasis. An experimental study in rabbits.
    Arnljots B; Dougan P; Salemark L; Bergqvist D
    Scand J Plast Reconstr Surg Hand Surg; 1994 Mar; 28(1):9-13. PubMed ID: 8029659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.